EP3504229
REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.8.2017EP published:
13.10.2021EP application number:
17844404.8
EPO information:
European Patent Register
Max expiry date:
23.8.2037
Title:
REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES
Timeline
Today
24.8.2017EP application
13.10.2021EP Publication
Owner
Name:
Sangamo Therapeutics, Inc.Address:
7000 Marina Blvd, Brisbane, CA 94005, US
Inventor
Name:
MILLER, Jeffrey C.Address:
Brisbane California 94005, US
Name:
REBAR, Edward J.Address:
Brisbane California 94005, US
Priority
Number:
201662378978 PDate:
24.8.2016Country:
US
Number:
201762443981 PDate:
9.1.2017Country:
US
Number:
201762545778 PDate:
15.8.2017Country:
US
Classification
Categories:
A61K 35/28, A61K 38/00, A61P 7/00, A61P 7/06, C12N 9/22, C12N 15/90